Schott Pharma AG KGaA (FRA:1SX) FFO


FRA:1SX Schott Pharma AG & CO KGaA FRA:1SX
67 GF Score
Price €4.06
GF Value €6.49
! 2 Warning Signs
View Full Analysis

What is Schott Pharma AG KGaA FFO?

FFO (Funds from operations) only applies to REITs.

FRA:1SX
67GF Score
Schott Pharma AG & CO KGaA FRA:1SX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Schott Pharma AG KGaA (FRA:1SX) Overvalued in 2026?

Based on GuruFocus' analysis, Schott Pharma AG KGaA stock appears to be undervalued. The current stock price of €4.06 is trading 37.4% below its estimated GF Value™ of €6.49.

Key valuation signals for FRA:1SX:

  • FFO:
  • GF Value™: €6.49 vs. price of €4.06 (37.4% below fair value)
  • GF Score™: 67/100 with 2 warning signs

No single metric tells the full story. See the FRA:1SX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Schott Pharma AG KGaA Business Description

Address Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Schott Pharma AG & CO KGaA is an international provider of drug containment solutions and delivery systems for injectable drugs for pharma, biotech and life-sciences. Its business operates in two segments: Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of revenue is being generated from the DCS segment, which includes products like vials, cartridges, and ampoules, and provides customers with sterile and non-sterile options in standard and high-end formats for drug storage. Geographically, the company generates revenue from Europe, the Middle East, Africa (EMEA), Asia and the South Pacific, North America, and South America.
67GF Score

Get the complete analysis for FRA:1SX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.06
Price
€6.49
GF Value